21 C
New York
Tuesday, June 22, 2021

Australia to receive first batch of AstraZeneca COVID-19 vaccine in January 2021 – PM to say

Must read

Let’s talk, says Spain, as jailed Catalan separatists are pardoned

World5 minutes ago (Jun 22, 2021 01:37PM ET) 2/2 (C) Reuters. FILE PHOTO: A protester waves an Estelada (Catalan separatist flag) during a demonstration outside the...

U.S. Fed bank stress tests pave way for stock buyback, dividend bonanza

(C) Reuters. FILE PHOTO: A combination file photo shows Wells Fargo, Citibank, Morgan Stanley, JPMorgan Chase, Bank of America and Goldman Sachs from Reuters...

U.S. Senate confirms Biden intel pick after Republicans cite Huawei link

Stock Markets7 minutes ago (Jun 22, 2021 01:35PM ET) (C) Reuters. WASHINGTON (Reuters) - The U.S. Senate on Tuesday confirmed President Joe Biden's nominee Christopher...

Jet Airways shares more than halved since closure of operations in 2019

NEW DELHI: Shares of Jet Airways, whose likely revival is in sight with NCLT approving a resolution plan, have lost more than half of...
imageCoronavirus1 hour ago (Sep 06, 2020 09:26AM ET)

2/2

(C) Reuters. People wear face masks in the city centre in Sydney

2/2

By Colin Packham

SYDNEY (Reuters) – Australia will receive the first doses of an AstraZeneca (NYSE:AZN) and Oxford University COVID-19 vaccine in January 2021 if trials prove successful, after Canberra agreed a deal to purchase a second potential vaccine, Prime Minister Scott Morrison will say on Monday.

Australia said in August it had signed a preliminary agreement with AstraZeneca for enough doses for its population of nearly 26 million, which would be manufactured locally by pharmaceutical company CSL (OTC:CSLLY).

That deal appeared in some doubt when CSL said its priority was manufacturing an alternative potential vaccine developed with the University of Queensland (UQ).

Agreeing a deal to overcome the potential roadblock, Australia will now also buy 51 million doses of the UQ vaccine.

It will take possession of the first 3.8 million doses of the AstraZeneca vaccine in January and February 2021, and then receive a further 30 million doses, Morrison will say in extracts from an announcement sent to Reuters.

AstraZeneca’s candidate is seen as a frontrunner in a global race to deliver an effective coronavirus vaccine.

“Australians will be among the first in the world to receive a safe and effective vaccine, should it pass late stage testing,” Morrison will say.

Under the deal with UQ and CSL, Australia will buy 51 million doses of that tie-up’s vaccine. The UQ and CSL candidate is scheduled to begin phase two trials in late 2020 and if all trials are successful it could be rolled out to Australians in mid-2021.

Both deals will cost in total A$1.7 billion ($1.24 billion), Morrison will say. Should both vaccines prove successful, Australia has secured to right to donate or sell on without a mark-up.

Health officials are discussing who will receive the first doses if trials are successful, Morrison will say. Vulnerable people, and front-line health care workers likely to be first in line, a source familiar with the details told Reuters.

The supply agreements come as Australia grapples with a second wave of infections in its second most populous state, Victoria. Australia has recorded more than 26,000 infections and 753 deaths.

(This story corrects to show announcement will be made on Monday not Tuesday)

Australia to receive first batch of AstraZeneca COVID-19 vaccine in January 2021 – PM to say

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

- Advertisement -

Latest article

Let’s talk, says Spain, as jailed Catalan separatists are pardoned

World5 minutes ago (Jun 22, 2021 01:37PM ET) 2/2 (C) Reuters. FILE PHOTO: A protester waves an Estelada (Catalan separatist flag) during a demonstration outside the...

U.S. Fed bank stress tests pave way for stock buyback, dividend bonanza

(C) Reuters. FILE PHOTO: A combination file photo shows Wells Fargo, Citibank, Morgan Stanley, JPMorgan Chase, Bank of America and Goldman Sachs from Reuters...

U.S. Senate confirms Biden intel pick after Republicans cite Huawei link

Stock Markets7 minutes ago (Jun 22, 2021 01:35PM ET) (C) Reuters. WASHINGTON (Reuters) - The U.S. Senate on Tuesday confirmed President Joe Biden's nominee Christopher...

Jet Airways shares more than halved since closure of operations in 2019

NEW DELHI: Shares of Jet Airways, whose likely revival is in sight with NCLT approving a resolution plan, have lost more than half of...

The 2 Best Pharma Stocks to Buy on Dips

Stock Markets12 minutes ago (Jun 22, 2021 01:30PM ET) (C) Reuters. The 2 Best Pharma Stocks to Buy on Dips The aging population in much of...